Lululemon Shares Slip After Texas Attorney General Launches Investigation Over Chemical Safety Claims

Lululemon Athletica saw its stock slide over 3% on Monday after the Texas Attorney General, Ken Paxton, initiated a probe into the company's product safety disclosures. The investigation targets whether Lululemon has potentially misled shoppers about the presence of harmful substances in its activewear.

Specifically, the Texas AG's office issued a Civil Investigative Demand to scrutinize if Lululemon's apparel contains PFAS - commonly labeled as "forever chemicals". These substances have garnered scrutiny due to links with serious health issues including hormone interference, fertility problems, and certain cancers.

The inquiry will examine the company's adherence to safety protocols, reviewing its Restricted Substances List, product testing practices, and supply chain oversight. The aim appears to be assessing alignment with the wellness and sustainability branding that Lululemon heavily promotes.

In fiscal year 2025, the athleticwear giant raked in revenues topping $11 billion, carving a niche as a premium lifestyle brand emphasizing health-conscious consumer values and environmental responsibility.

Attorney General Paxton emphasized consumer protection, stating there's no room for companies to pass off harmful materials as wellness-focused products, especially at premium price points. This stance underscores increasing regulatory pressures on brands touting eco-friendly and health-related benefits.

Market reaction was swift, with investors seemingly unsettled by regulatory uncertainties, resulting in a noticeable dip in share price. The outcome of this probe could have repercussions for other apparel companies marketing themselves on sustainability and safety claims.

This development raises the question of how rigorous product transparency standards really are across the apparel industry and whether consumers are receiving the full picture behind their purchases.

As the investigation unfolds, details about Lululemon's internal controls and chemical use practices will be under the microscope, potentially adding pressure on similar firms to re-evaluate their product disclosures and testing regimes.